Rallybio Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

Rallybio Corp reported Cash And Cash Equivalents At Carrying Value of $31.37 million for the year ending 2025.

  • Rallybio Corp showed an increase of +125.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Rallybio Corp's annual report (Form 10-K), filed with the SEC on March 16, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Rallybio Corp's Cash And Cash Equivalents At Carrying Value has declined by 77.6%.
  • Historical annual values: Fiscal year 2025: $31.37 million | Fiscal year 2024: $13.90 million | Fiscal year 2023: $24.49 million | Fiscal year 2022: $56.96 million | Fiscal year 2021: $175.33 million | Fiscal year 2020: $140.23 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: